CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 57 enrolled
Drug / intervention
Endovascular Treatment (EVT)procedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02618031
NCT02618031Phase 1Completed
CompareCT.gov

The Capillary Index Score Trial: Phase I

Firas Al-Ali·interventional·Posted Dec 1, 2015·Updated Feb 5, 2020

In Brief

A Phase 1 clinical trial evaluating Endovascular Treatment (EVT) for Acute Stroke and 2 related conditions. Completed, enrolled 57 participants across 6 sites.

Detailed Summary

This study seeks to investigate the capillary index score (CIS) to further improve patient selection of endovascular treatment (EVT) in acute ischemic stroke (AIS). The hypothesis or idea being tested: Patients with favorable CIS who are successfully revascularized with EVT can have successful outcomes with an extended time window for treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Stroke, Brain Ischemia, Ischemic Stroke
CountriesUnited States
CollaboratorsStryker Neurovascular, Rochester General Hospital, University of Vermont Medical Center, University of North Carolina, Chapel Hill, NYU Langone Health, WellStar Health System

Timeline

Phase 1CompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 1, 2015
Enrollment StartMar 1, 2016
Primary CompletionAug 31, 2018
Study CompletionDec 31, 2018
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 10.6 years ago

Interventions

Endovascular Treatment (EVT)procedure

EVT is an endovascular procedure in which a catheter is inserted into an artery and directed to the site of the blocked blood vessel in the brain. The clot is removed using a mechanical device with or without an injection of tPA (tissue plasminogen activator) directly at the site of the clot. The protocol calls for use of the Trevo stent retriever (Stryker Neurovascular) for the first pass of clot removal.